Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing RNA extraction methods to face the variations in RNA quality using two human biological matrices.
Ortega-Pinazo J, Pacheco-Rodríguez MJ, Serrano-Castro PJ, Martínez B, Pinto-Medel MJ, Gómez-Zumaquero JM, Lago-Sampedro A, García-Díaz B, Estivill-Torrús G, Emilio Ferro Gallego P. Ortega-Pinazo J, et al. Among authors: pinto medel mj. Mol Biol Rep. 2023 Nov;50(11):9263-9271. doi: 10.1007/s11033-023-08761-2. Epub 2023 Oct 9. Mol Biol Rep. 2023. PMID: 37812354
Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients.
López-Gómez C, Pino-Ángeles A, Órpez-Zafra T, Pinto-Medel MJ, Oliver-Martos B, Ortega-Pinazo J, Arnáiz C, Guijarro-Castro C, Varadé J, Álvarez-Lafuente R, Urcelay E, Sánchez-Jiménez F, Fernández Ó, Leyva L. López-Gómez C, et al. PLoS One. 2013 Apr 29;8(4):e62540. doi: 10.1371/journal.pone.0062540. Print 2013. PLoS One. 2013. PMID: 23658636 Free PMC article.
Skin Phototype Could Be a Risk Factor for Multiple Sclerosis.
Urbaneja P, Hurtado-Guerrero I, Hernández MÁ, Oliver-Martos B, Oreja-Guevara C, Ortega-Pinazo J, Alonso A, Barón-López FJ, Leyva L, Fernández Ó, Pinto-Medel MJ. Urbaneja P, et al. Among authors: pinto medel mj. J Clin Med. 2020 Jul 26;9(8):2384. doi: 10.3390/jcm9082384. J Clin Med. 2020. PMID: 32722577 Free PMC article.
TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis.
López-Gómez C, Fernández O, García-León JA, Pinto-Medel MJ, Oliver-Martos B, Ortega-Pinazo J, Suardíaz M, García-Trujillo L, Guijarro-Castro C, Benito-León J, Prat I, Varadé J, Álvarez-Lafuente R, Urcelay E, Leyva L. López-Gómez C, et al. PLoS One. 2011;6(7):e21766. doi: 10.1371/journal.pone.0021766. Epub 2011 Jul 21. PLoS One. 2011. PMID: 21814551 Free PMC article.
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.
Dominguez-Mozo MI, Perez-Perez S, Villar LM, Oliver-Martos B, Villarrubia N, Matesanz F, Costa-Frossard L, Pinto-Medel MJ, García-Sánchez MI, Ortega-Madueño I, Lopez-Lozano L, Garcia-Martinez A, Izquierdo G, Fernández Ó, Álvarez-Cermeño JC, Arroyo R, Alvarez-Lafuente R. Dominguez-Mozo MI, et al. Among authors: pinto medel mj. Sci Rep. 2020 Aug 28;10(1):14244. doi: 10.1038/s41598-020-71283-5. Sci Rep. 2020. PMID: 32859922 Free PMC article.
Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß.
Hurtado-Guerrero I, Pinto-Medel MJ, Urbaneja P, Rodriguez-Bada JL, León A, Guerrero M, Fernández Ó, Leyva L, Oliver-Martos B. Hurtado-Guerrero I, et al. Among authors: pinto medel mj. PLoS One. 2017 Jan 19;12(1):e0170031. doi: 10.1371/journal.pone.0170031. eCollection 2017. PLoS One. 2017. PMID: 28103257 Free PMC article.
29 results